Business Wire

Lenovo and Pivot3 Optimize Smart City Security

Del

Lenovo (HKSE: 992) (ADR: LNVGY), a Fortune Global 500 company and global technology leader in driving Intelligent Transformation, and Pivot3, a leading provider of hyperconverged infrastructure solutions (HCI), today announced a global strategic partnership to develop, market and sell a new set of edge computing solutions optimized for mission-critical smart city security. The integrated appliances feature Lenovo Data Center Group (DCG) ultra-reliable ThinkSystem servers powered by Pivot3 HCI software.

Much of the smart city market growth is being driven by mission-critical security initiatives which rely on information collated from an array of city sensors and databases combined with video data and analytics including facial recognition, behavioral analysis, license plate recognition and other intelligence. According to IHS Markit, the global market for security equipment in the city surveillance sector has surpassed $3 billion in 2017 and is expected to grow at an average rate of 14.6 percent through 20211. Effectively collecting, analyzing, storing and acting on all this information in real-time relies on the latest advances in edge computing. The Lenovo/Pivot3 solution provides this growing market with resilient, cost effective and easy-to-manage edge computing.

“Together Lenovo and Pivot3 are enabling the next generation of edge computing, where governments and organizations can leverage machine learning and analytics to better protect the people they serve,” said Wilfredo Sotolongo, vice president and general manager of IoT at Lenovo Data Center Group. “Through this partnership, we provide customers a solution to centrally manage their distributed edge devices – with faster video ingest rates, higher resiliency and smaller, space conscious appliances.”

“We are thrilled to team up with Lenovo, a partner and industry leader that shares our commitment to supporting the evolving data center,” said Bruce Milne, chief marketing officer and general manager, Lenovo Alliance, Pivot3. “Pivot3 and Lenovo support customers with streamlined service delivery, automation and efficiency. Customers are seeing incredible impact from our HCI solutions that are optimized for mission-critical safe city, IoT and edge computing, and we’re pleased to further expand that impact with Lenovo’s market influence, distribution and accelerated go-to-market strategies.”

Among the growing customer base is the City of Bogotá, Colombia, that needed to refresh its complex monitoring system of over 1000 cameras of different vendors. The City of Bogotá is deploying a highly efficient Lenovo/Pivot3 edge computing solution to achieve maximum infrastructure efficiency and scale the entire security network into a central control center, out of which at least four visualization locations operated by police will be served. With this new deployment in edge computing, the City of Bogotá is now able to seamlessly scale performance requirements as surveillance needs grow. Following this initial deployment for the City of Bogotá, the suburbs of Bogotá additionally chose the combined Pivot3-Lenovo technology for another 2,000 cameras located along the city's 18 boroughs.

“With this new scalable edge computing solution, the city’s security team can view any camera, regardless of brand across the city from a single location, which will greatly simplify operations,” said Rafael Padilla, systems integrator, City of Bogotá Safe City Project.

The new Lenovo/Pivot3 solution is currently available and installed in markets across the globe. Proof-of-concept testing is also available at Lenovo’s Innovation Centers, where customers and partners can gain real-time insight into how the IoT solutions can perform within their unique environments, workloads and data.

To keep up with future IoT announcements, thought leadership pieces and more from Lenovo DCG, visit http://www.LenovoXperience.com

About Lenovo

Lenovo (HKSE: 992) (ADR: LNVGY) is a US$45 billion Fortune Global 500 company and a global technology leader in driving Intelligent Transformation through smart devices and infrastructure that create the best user experience. Lenovo manufactures one of the world’s widest portfolio of connected products, including smartphones (Motorola), tablets, PCs (ThinkPad, Yoga, Lenovo Legion) and workstations as well as AR/VR devices and smart home/office solutions. Lenovo’s data center solutions (ThinkSystem, ThinkAgile) are creating the capacity and computing power for the connections that are changing business and society. Lenovo works to inspire the difference in everyone and build a smarter future where everyone thrives. Follow us on LinkedInFacebookTwitterInstagramWeibo, read about the latest news via our Storyhub, or visit our website at http://www.lenovo.com/

About Pivot3

Pivot3’s intelligent hybrid cloud and IoT solutions provide security, resilience and simplicity at scale for customers’ mission-critical business services. Powered by the industry’s only Intelligence Engine, Pivot3 automates the management of applications, delivers industry-leading performance, eliminates unplanned downtime and reduces the cost of traditional IT infrastructure by half or more. With over 2,600 customers in 63 countries, and more than 20,000 deployments in education, hospitality, transportation, government, healthcare, defense, financial services and retail, Pivot3 allows IT to manage complexity at scale through automation and intelligence. Visit www.pivot3.com to learn more.

1 Jacky Zhang, “Video Surveillance & Security Report - Cities - 2018” IHS Markit, January 10, 2018

Contact information

Lenovo Press Contacts
North America – David Hamilton, dhamilton1@lenovo.com, +1 864 979 0024
Europe – Judith Schunke, jschunke@lenovo.com, +44 7500 922556
Zeno Group LenovoWWDCG@zenogroup.com
or
Pivot3 Press Contact
Liz Cies, lcies@ideagrove.com , +1 972 850 5855

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

IONITY Fast Charging Network Relies on has·to·be Know-How for the Long Term24.4.2019 10:18:00 CESTPressemelding

The IONITY joint venture aims to help electromobility achieve a breakthrough in Europe with a nationwide network of super-fast charging stations. The Austrian electromobility provider, has·to·be, is playing an important role in this. The red-white-red company will take care of the reliable and trouble-free operation of the charging stations. The two companies have agreed on a long-term cooperation so that the expansion of the Europe-wide network can proceed according to plan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190424005465/en/ has·to·be and IONITY focus on long-term cooperation (Graphic: Business Wire) has·to·be, based in Radstadt (Salzburg), specializes in smart solutions for e-charging stations. For this purpose, the company has developed intelligent software for the management of electrical charging infrastructures. The product is called be.ENERGISED and is used successfully at more than 14,000 charging statio

Knopp Biosciences Receives FDA Orphan Drug Designation for Dexpramipexole for Treatment of Hypereosinophilic Syndrome24.4.2019 10:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with high unmet needs, announced today that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to dexpramipexole, its oral drug candidate for the treatment of hypereosinophilic syndrome (HES). HES is a rare and often incapacitating disorder with limited treatment options. The FDA Orphan Drug Designation program provides a special status to drugs and biologics intended to treat, diagnose, or prevent diseases and disorders that affect fewer than 200,000 people in the U.S. This designation provides for a seven-year marketing exclusivity period against competition, as well as certain incentives, including federal grants, tax credits and a waiver of PDUFA filing fees. “We are very pleased to receive orphan drug designation for dexpramipexole for HES,” said Michael Bozik, M.D., CEO of Knopp Biosc

Enterprise Integration Middleware Leader, Fiorano Software, Announces Release of Fiorano Platform 12.024.4.2019 09:00:00 CESTPressemelding

Fiorano Software, a leader in Integration Middleware, API Management and peer-to-peer distributed systems, announced today the release of version 12.0 of the Fiorano ESB and API Management platform. The latest release with new adapters and tools includes enhanced and optimised features to improve performance of its servers delivering a more productive SOA and API Management deployment with a significant incremental return on investment. The platform offers a unified profile to run all Fiorano Servers in a single process and ships with several new adapters including a Kafka Connector, DynamoDB, AS4Connector, SMPPSend and WebSockets. Users can now import Event Processes directly from the Dashboard and optimize CRC processes by fetching components from local repositories. The new platform provides a new HTML5 dashboard, monetisation and security policies like JWT/JWS for API Management while supporting Open API specifications, OpenId Connect and time-based accessing and quota policies alo

Aptorum Group’s Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT™24.4.2019 08:30:00 CESTPressemelding

Aptorum Group Limited (Nasdaq:APM) is excited to announce the launch and issuance of its asset backed Smart Pharma Token (“SMPT”) by its wholly owned subsidiary group, Smart Pharma group and Smart Pharmaceutical Limited Partnership (“SPLP”) targeted in May 2019. SPLP is extremely pleased to have jointly developed the SMPT token with Aenco, an affiliated blockchain development company focused on applications in the healthcare and financial sector. The SMPT token, an ERC-1404 security compliant token, is a unique token that tokenizes valuable pharmaceutical drugs and their underlying intellectual property and associated allocation of cash flows induced by continual product development and commercialization. It is the intention of the Smart Pharma group to continue to incorporate Aenco’s blockchain technology into its pharmaceutical development and commercialization processes. Relying on intellectual property derived from the Smart-ACT™ platform, Smart Pharma’s in-house new and repurposed

Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases24.4.2019 08:30:00 CESTPressemelding

Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma (“SmartP”), which operates its novel computational repurposed drug discovery, modeling and validation platform, together referred to as the “Smart-ACTTM” platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190424005095/en/ (Photo: Business Wire) Smart-ACTTM stands for Accelerated Commercialization of Therapeutics and encompasses state-of-the-art technology in systematic screening of existing approved drug molecules against selected therapeutic targets. Specifically, the Smart-ACTTM platform comprises of a network of modules and processes that simulate the effectiveness of drug molecules against diseases for outcome prediction and selection. The Smart-ACTTM platform will initially focus on the screening drug molecules for orphan diseases or unmet medical needs. To date, SmartP has, under the recently established

Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 201924.4.2019 08:15:00 CESTPressemelding

Aptorum Group Limited (NASDAQ: APM) (“Aptorum” or the “Company”), a pharmaceutical company focused on the development and commercialization of therapeutic and diagnostic technologies to tackle unmet medical needs, announced today that the Company, in a privately-negotiated transaction, repurchased all outstanding US$13,500,000 in aggregate principal amount of the 8.00 per cent. convertible bonds due 2019 (“Convertible Bonds”) from Peace Range Limited, a wholly owned subsidiary of Adamas Ping An Opportunities Fund LP, together with certain subscription right to subscribe up to the principal amount of the Bond at a US$12.17 (subject to adjustment) on or before December 17, 2019 (“Subscription Right”). The total consideration of the repurchase of the Convertible Bonds and the Subscription Right was US$13.6 million in cash, excluding accrued interest. The repurchase of the Convertible Bonds and Subscription Right was executed by Aptorum Investment Holding Limited, a wholly owned subsidiary